SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetir Plc Regulatory News (MET)

Share Price Information for Metir Plc (MET)

Share Price is delayed by 15 minutes
Get Live Data
0.85    0.00 (0.00%)
Bid:
0.80
Ask:
0.90
Spread: 0.10 (12.50%)
Market Cap: £3.77m
MET Live PriceLast checked at - London Stock Exchange

Intraday Metir Plc Share Chart

Trading Statement

13 Jan 2026 07:00

RNS Number : 6056O
Metir PLC
13 January 2026
 

 

13 January 2026

Metir plc

 

("Metir", the "Group" or the "Company")

 

Trading Update

 

Metir plc (AIM: MET), the leading global provider of fast-response, mobile and point-of-use water and environmental monitoring technologies, is pleased to provide a trading update for the financial year ended 31 December 2025 ("FY25"). The Group's Annual Report and Accounts are expected to be published in May 2026.

 

Trading in FY25 was in line with management expectations, with growth driven by increased international demand for Microtox® LX instruments, Microtox® reagents and Sulphate Reducing Bacteria ("SRB") kits, alongside continued progress in large-scale potable water monitoring projects with the Continuous Toxic Monitoring ("CTM") installation in Qatar. The Group expects to report revenues of £1.5m (31 December 2024: £0.23m) and a cash balance at the year-end of £1.04m following the successful fundraise of £1.0m, before expenses, completed on 22 December 2025.

 

The Group has continued to build on the momentum reported in its interim results announced on 30 September 2025 and the trading update released on 2 December 2025. Customer demand for Microtox® LX instruments remained strong throughout the second half of the year. Although outsourced manufacturing output increased during H2 2025, production capacity was limited during Q4 2025, constraining the pace at which customer demand could be converted into revenue. Due to these restrictions, 10 of the 56 Microtox® LX instruments ordered in FY25 could not be fulfilled; however, they are now being manufactured and will be delivered in early 2026. Increasing the outsourced manufacturing capacity of Microtox® FX instruments is a key near-term objective in 2026 following increased sales interest.

 

The growing installed base of Microtox® LX and FX instruments is expected to drive demand for high-margin Microtox® reagents. The Board believes that unlocking this high-margin recurring revenue stream is a significant financial objective for the business, with a focus on not only increasing manufacturing capacity, but also working with customers to drive greater reagent usage.

 

Demand for SRB kits, which were relaunched in June 2025, remained robust. Customer interest increased materially, with quotations provided to more than 60 companies worldwide. During Q4 2025, production of SRB kits was temporarily paused due to a manufacturing quality control assessment. The objective is to restart production as soon as practicable, possibly using an alternative biological component to ensure Modern Water's QuickChek™ SRB kit remains the market-leading fast response product.

 

Throughout FY25, the Board continued to prioritise investment in scaling-up manufacturing, product development and commercial capability, consistent with the Group's strategy to build a growing recurring-revenue business for its current product range. In addition, Metir is developing what it believes could be significant future revenue streams from new technologies, including its proprietary mobile PFAS testing technology with Swansea University, and progressing towards completion of the Cryptosporidium project in 2026 with Aptamer Group plc for deployment of a commercial real-time continuous Pathogen Detector.

 

The Group completed a fundraising in December 2025 to strengthen working capital, accelerate manufacturing output and therefore support the conversion of a growing order book into revenue. The Board believes this additional funding materially improves the Group's ability to execute its near-term growth plans and to increase margins on its products.

 

Metir has growing revenues from multiple and diverse Modern Water product streams. Ongoing development of the Group's unique mobile PFAS detection and Pathogen Detection technologies will increase the product portfolio further.

 

Bob Moore, Executive Chairman and Chief Executive Officer of Metir plc, commented:

 

"FY25 marked a year of strong commercial progress for Metir, with customer demand continuing to grow across Modern Water's instrument, reagent and testing kit portfolio. While manufacturing capacity constrained the Group's ability to fully meet demand during the year, the underlying momentum in the business is encouraging for sales growth throughout 2026.

 

"With enhanced funding in place, a growing installed base of instruments and an expanding international pipeline, we enter this year with increased confidence. The Board believes the actions taken during FY25, including further product development, provide a solid foundation for accelerating production of the Group's instrumentation and reagents, driving revenue growth and progressing towards sustainable profitability.

 

"We look forward to reporting progress on the Group's growth initiatives over the coming months."

 

- Ends -

 

Enquiries:

 

Metir plc

Bob Moore, Executive Chairman and Chief Executive Officer

+44 (0) 20 3657 0050

via TPI

 

 

Singer Capital Markets(Nominated Adviser & Joint Broker)

Alex Bond

+44 (0)20 7496 3000

 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andrew Thacker / Guy McDougall 

+44 (0) 20 3657 0050

 

Northstar Communications (Investor Relations)

Sarah Hollins

+44 (0) 113 730 3896

 

About Metir

 

Metir plc is a leading global provider of several fast-response, mobile and point-of-use water and environmental monitoring technologies. Through its two established trading divisions, Modern Water and Microsaic Systems, a specialist in mobile PFAS monitoring, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water and liquids quality results, helping industries, utilities and regulators monitor safety and compliance in real time.

 

With a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.

 

Headquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.

 

For more information, please visit: https://www.metirplc.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDXGDBGSBDGLD
Date   Source Headline
8th Oct 20131:58 pmRNSHolding(s) in Company
23rd Sep 20137:00 amRNSHalf Yearly Report
26th Jul 20132:13 pmRNSResult of AGM
3rd Jul 20135:52 pmRNSNotice of AGM
1st Jul 20137:00 amRNSAnnual Financial Report
28th Jun 20134:45 pmRNSFinal Results
17th Apr 20137:00 amRNSDisposal
10th Apr 201311:20 amRNSProperty Disposal
2nd Nov 20123:49 pmRNSLitigation Update
29th Oct 20127:30 amRNSChange of Adviser
8th Oct 20127:00 amRNSIssue of legal proceedings
28th Sep 20127:00 amRNSHalf Yearly Report
31st Jul 201211:00 amRNSResult of AGM
27th Jul 20127:00 amRNSOffer Update
26th Jul 20126:08 pmRNSLitigation update (replacement)
26th Jul 20129:05 amRNSLitigation update
23rd Jul 20126:19 pmRNSHolding(s) in Company+Director shareholding
20th Jul 20123:36 pmRNSOffer Rejection
20th Jul 20127:00 amRNSIrrevocable undertaking to accept the Offer
19th Jul 20125:00 pmRNSOffer Document Posted
19th Jul 20127:00 amRNSCash Offer for Metro Baltic Horizons plc
2nd Jul 20129:44 amRNSAnnual Financial Report
2nd Jul 20127:00 amRNSFinal Results
20th Apr 20129:37 amRNSAppointment of New Auditor
22nd Feb 201210:05 amRNSHolding(s) in Company
9th Nov 20113:06 pmRNSResult of AGM
26th Oct 201112:03 pmRNSCorrection to Result of Annual General Meeting
25th Oct 20112:34 pmRNSResult of AGM
30th Sep 20117:00 amRNSHalf Yearly Report
29th Sep 20113:53 pmRNSNotice of AGM
10th Aug 20112:19 pmRNSHolding(s) in Company
3rd Aug 20117:30 amRNSRestoration - Metro Baltic Horizons plc
3rd Aug 20117:01 amRNSTrading Statement
3rd Aug 20117:00 amRNSFinal Results
13th May 20114:32 pmRNSDirectorate Change
12th May 20113:37 pmRNSDirectorate Change
15th Apr 20113:22 pmRNSAppointment of Director
15th Feb 201112:25 pmRNSTrading Update
2nd Dec 20103:29 pmRNSBoard Changes
15th Nov 20102:36 pmRNSResignation
15th Nov 20107:00 amRNSSuspension of Shares
11th Nov 201012:00 pmRNSTemporary Suspension
1st Nov 20109:21 amRNSAppointment of Directors
15th Oct 20103:37 pmRNSInvestment Transaction
30th Sep 20104:13 pmRNSHalf Yearly Report (Replacement)
30th Sep 20101:12 pmRNSHalf Yearly Report
27th Jul 20105:14 pmRNSResult of AGM
30th Jun 20109:21 amRNSPosting of Annual Report & Accounts
24th Jun 20101:23 pmRNSFinal Results
4th Mar 20107:00 amRNSDebt Equity Swap

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.